Fred Hassan - 03 Sep 2024 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Director
Signature
/s/ Ron Honig, Attorney-in-Fact
Issuer symbol
EYPT
Transactions as of
03 Sep 2024
Net transactions value
$0
Form type
4
Filing time
05 Sep 2024, 16:02:41 UTC
Previous filing
25 Jun 2024
Next filing
11 Oct 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Stock Options (Right to buy) Award $0 +60,000 $0.000000 60,000 03 Sep 2024 Common Stock 60,000 $8.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option becomes exercisable in three ratable annual installments beginning on September 3, 2025.